APA

Jakobson T., Kahanpää A. & Berglund B. (19660319). Experience with phenylethylbiguanide (DBI) tablets and timed-disintegration capsules (DBI-TD) administered as an adjunct to insulin or sulfonylurea drugs in previously treated diabetic patients. : Annales medicinae internae Fenniae.

Chicago

Jakobson T, Kahanpää A and Berglund B. 19660319. Experience with phenylethylbiguanide (DBI) tablets and timed-disintegration capsules (DBI-TD) administered as an adjunct to insulin or sulfonylurea drugs in previously treated diabetic patients. : Annales medicinae internae Fenniae.

Harvard

Jakobson T., Kahanpää A. and Berglund B. (19660319). Experience with phenylethylbiguanide (DBI) tablets and timed-disintegration capsules (DBI-TD) administered as an adjunct to insulin or sulfonylurea drugs in previously treated diabetic patients. : Annales medicinae internae Fenniae.

MLA

Jakobson T, Kahanpää A and Berglund B. Experience with phenylethylbiguanide (DBI) tablets and timed-disintegration capsules (DBI-TD) administered as an adjunct to insulin or sulfonylurea drugs in previously treated diabetic patients. : Annales medicinae internae Fenniae. 19660319.